POM-V Prescription Required

Rispoval 2 / BRSV + Pi3 Lyophilisate and Solvent for Suspension for Injection for Cattle

Active ingredients: Bovine parainfluenza virus 3, Bovine respiratory syncytial virus

Form

Injection

Species

Cattle

Manufacturer

Zoetis UK Limited

VMD MA No.

42058/5144

What it's used for

For vaccination with Rispoval 2 only: Active immunisation of cattle from 12 weeks of age to: - - Onset of immunity: 3 weeks after the basic vaccination sch...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Bovine parainfluenza virus 3...

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Rispoval 2 / BRSV + Pi3 Lyophilisate and Solvent for Suspension for Injection for Cattle — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

For vaccination with Rispoval 2 only:
Active immunisation of cattle from 12 weeks of age to:
-
-
Onset of immunity: 3 weeks after the basic vaccination scheme.

Revised October 2024
AN: 02386/2023
Duration of immunity: 6 months after the basic vaccination scheme for BRSV. Duration of
immunity has not been established for bovine Pi3V.
For active immunisation with Rispoval RS+Pi3 IntraNasal* as basic vaccination and
Rispoval 2 as booster vaccination from 13 weeks of age to:
- reduce the virus excretion caused by bovine Pi3V and BRSV infection and
- reduce the clinical signs (cough, depression, dyspnea, increased respiratory rate,
elevated rectal temperature) associated with BRSV infection.
Onset of Immunity: 3 weeks after the booster vaccination.
Duration of Immunity: 6 months for BRSV and 3 months for Pi3V after the booster
vaccination.
* Where this veterinary medicinal product is authorised.

None.

Cattle:
Very common
(>1 animal / 10 animals treated):
Hyperthermia
Injection site inflammation
Very rare
(<1 animal / 10,000 animals
treated, including isolated reports):
Hypersensitivity reaction (e.g. anaphylactic-type
reaction)
1
Transient and mild; can last for 2 days.

Revised October 2024
AN: 02386/2023
Transient and minor; up to 0.5 cm which disappears within 15 days.
In case of anaphylactic reaction, symptomatic treatment should be provided.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See the package leaflet for respective contact details.

Vaccinate healthy animals only.

Special precautions for use in animals
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
In case of accidental self-injection, seek medical advice immediately and show the package
leaflet or the label to the physician.
Special precautions for the protection of the environment
Not applicable.
Other precautions
Not applicable.

No information is available on the safety and efficacy of this vaccine when used with any
other veterinary medicinal product. A decision to use this vaccine before or after any other
veterinary medicinal product therefore needs to be made on a case by case basis.

Store and transport refrigerated (2 °C – 8 °C).
Do not freeze.
Protect from light.

- 10
8.6
CCID50.
Bovine respiratory syncytial virus (BRSV), strain 375, live 10
5.0
- 10
7.2
CCID50.
CCID50 = Cell Culture Infectious Dose 50%.
Adjuvant:
Aluminium hydroxide gel 0.8 ml (equivalent to 24.36 mg of aluminium hydroxide).
Excipients:
For the full list of excipients, see section

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.